
Envista Announces Participation in Bank of America 2023 Health Care Conference in Las Vegas
Envista Holdings Corporation announced that the company will participate in the Bank of America Health Care Conference in Las Vegas on Tuesday, May 9, 2023,

Envista Holdings Corporation announced that the company will participate in the Bank of America Health Care Conference in Las Vegas on Tuesday, May 9, 2023,

Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its first quarter 2023 on Wednesday, May 3, 2023. Envista will discuss these results on

Envista Holdings Corporation announced that the company will be holding an Investor Access Event at its Envista Summit on Friday, February 24th from 8 AM

Envista Holdings Corporation will report financial results for its fourth quarter 2022 on Wednesday, February 8, 2023. Envista will discuss these results on a conference

Envista Holdings Corporation announced that the company will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 from 3:00 – 3:40

Envista Holdings Corporation has announced results for the third quarter of 2022. As previously disclosed, on December 31, 2021, we completed the sale of the

Envista Holdings Corporation announced that the company will participate in the Piper Sandler MedTech and Diagnostics California Bus Tour on Wednesday, August 24, 2022, from 10:00

Envista Holdings Corporation (“Envista”) announced an extension and expansion of their commercial partnership with dentalcorp Holdings Ltd., Canada’s largest DSO, network of dental practices. Envista

Envista Holdings Corporation has announced that the company will participate in Stifel 2022 Jaws & Paws Conference on Wednesday, June 1, 2022, from 9:45 – 10:15

Envista Holdings Corporation has announced the completion of the acquisition of Carestream Dental’s Intraoral Scanner business. As previously announced, this business will be rebranded as DEXIS

Envista Holdings Corporation announced the 510(k) Food and Drug Administration (FDA) clearance of its Assisted Intelligence (AI) mandibular nerve tracing feature in its image acquisition and

Envista Holdings Corporation has announced that Envista’s KaVo imaging business will be re-branded as “DEXIS.” Dental professionals have known the DEXIS brand as the leader in